Louisiana 2024 Regular Session

Louisiana House Bill HB421

Introduced
2/29/24  
Introduced
2/29/24  
Refer
2/29/24  
Refer
2/29/24  
Refer
3/11/24  
Refer
3/11/24  
Report Pass
3/27/24  
Report Pass
3/27/24  
Engrossed
4/8/24  
Engrossed
4/8/24  
Refer
4/9/24  
Refer
4/9/24  
Report Pass
5/8/24  
Report Pass
5/8/24  
Refer
5/13/24  
Refer
5/13/24  
Enrolled
5/30/24  
Enrolled
5/30/24  
Chaptered
6/11/24  

Caption

Provides relative to sickle cell disease management and treatment plan for students diagnosed with sickle cell disease (EN NO IMPACT See Note)

Companion Bills

No companion bills found.

Previously Filed As

LA HR289

Requests the Louisiana Department of Health to review Medicaid prior authorization criteria for L-glutamine which is used to treat acute complications caused by sickle cell disease

LA HR201

Creates a subcommittee to study the effectiveness of sickle cell healthcare treatment practices in this state

LA HB69

Provides for the screening and diagnosis of students with respect to dyslexia (EN INCREASE GF EX See Note)

LA HB55

Provides relative to mental health treatment of incarcerated people (EN NO IMPACT See Note)

LA SB104

Provides for health insurance coverage of genetic testing for diseases and other medical conditions. (8/1/23) (EN INCREASE GF EX See Note)

LA SB66

Provides relative to telehealth services. (1/1/24) (EN NO IMPACT See Note)

LA HB435

Provides relative to medicaid coverage of chimeric antigen receptor T-cell therapy (EN SEE FISC NOTE GF EX See Note)

LA HB468

Provides relative to utilization review standards and approval procedures for healthcare service claims submitted by healthcare providers (EN NO IMPACT See Note)

LA HB41

Provides relative to health coverage plan benefits for occupational therapy services delivered via telehealth (EN NO IMPACT See Note)

LA HB548

Provides relative to the 340B drug pricing program (EN NO IMPACT See Note)

Similar Bills

No similar bills found.